Table 2.
Treatment regimen | Response rate |
---|---|
First-line ADT (n = 20) | 55% |
Leuprolide + Bicalutamide (n = 14) | 5 CR, 4 PR, 4 PD, 1 Unknown |
Leuprolide (n = 1) | 1 PD |
Bicalutamide (n = 2) | 2 PR |
Enzalutamide (n = 3) | 1 SD, 2 PD |
Salvage ADT after 1st line ADT (n = 6) | 16.7% |
Leuprolide + Bicalutamide (n = 2) | 1 SD, 1 PD |
Leuprolide (n = 1) | 1 CR |
Enzalutamide (n = 1) | 1 SD |
Leuprolide + Abiraterone (n = 1) | 1 SD |
Abiraterone (n = 1) | 1 PD |
Salvage ADT after 1st line Chemo (n = 6) | 16.7% |
Leuprolide + Bicalutamide (n = 2) | 1 PR, 1 SD |
CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease.